Smooth muscle (sm) a-actin is expressed in vascular smooth muscle cells and ®broblast cells. Its expression is regulated by cell proliferation and repressed during oncogenic transformation. In this study, we demonstrate that p53 activation is associated with a dramatic increase in organized micro®lament bundles and an increase in sm a-actin mRNA level. Wild-type p53, but not mutant p53, strongly stimulated human sm a-actin promoter activity in p53 null cell lines. The sequences homologous to the p53 consensus sequence and to the p53 binding sequence from the muscle creatine kinase, were found within a speci®c region of the sm a-actin promoter. This sequence was sucient to confer p53-dependent activation to a heterologous promoter and p53 was capable of binding to this sequence as assessed by gel shift analysis. Ionizing irradiation of colorectal tumor cells caused an increase in a-actin mRNA level in a p53-dependent manner. Taken together, these results demonstrate that human sm aactin gene is a transcriptional target for p53 tumor suppressor protein and represents the ®rst example of a cytoskeletal gene with a functionally de®ned p53 response element.
Introduction
The p53 tumor suppressor protein is a transcriptional regulator which activates the transcription of target genes by binding to speci®c p53-binding sites (Ko and Prives, 1996) . A 20 bp consensus-binding site, consisting of two copies of the 10 bp sequence 5'-PuPuPuC(A/T)(T/A)GpyPyPy-3' separated by up to 13 bp, has been identi®ed as the p53-consensus sequence . A number of transcriptional targets of p53 have been identi®ed. These include, mdm-2, gadd45, p21/WAF, cyclin G, IGF-BP3, bax, etc., Barak et al., 1993; Kastan et al., 1992; El-Deiry et al., 1993; Okamoto and Beach, 1994; Buckbinder et al., 1995; Miyashita and Reed, 1995) . The proteins encoded by these target genes participate mainly in either cycle control or in the apoptotic pathway. Other genes such as sgk (serum/glucocorticoid inducible serine/threonine protein kinase) and muscle creatine kinase (mck), that are not directly involved in cell cycle control have also been identi®ed as targets for positive regulation by p53 Maiyer et al., 1996) . The functional signi®cance of the regulation of these genes by p53 is not very well understood. p53 has also been reported to repress genes lacking p53-binding sites, possibly by binding to and sequestering essential transcription factors, such as TATA-binding protein (TBP) (Seto et al., 1992) and CCAAT binding factor (CBF) (Ago et al., 1993) .
p53 is regarded as one of the most important tumor suppressors, whose alterations are among the most common genetic alterations found in human tumors (Greenblatt et al., 1994) . p53 contributes to tumor suppression through at least two mechanisms, arrest of cell cycle progression and induction of cell death through apoptosis. Induction of p53 protein by DNA damage results in cell cycle arrest or apoptosis (Nelson and Kastan, 1994) , potentially protecting cells from accumulating excess mutations and/or inappropriate cell survival (Symonds et al., 1994) .
Cell cycle progression is associated with dramatic changes in the organization of cytoskeletal ®laments (Yamashiro and Matsumara, 1991; Mabuchi, 1986) . These changes include the disassembly of micro®lament bundles during prophase accompanied by the rounding-up of cultured cells, the formation of contractile rings during cytokinesis and subsequently the reassembly of micro®lament bundles and the respreading of two daughter cells (Mabuchi, 1986) . Cell cycle arrest is also associated with dramatic changes in the organization of the micro®lament structures (Kajstura and Bereiterhahn, 1993) . We have recently shown that antimitotic agents that act either by stabilizing or destabilizing microtubules, induce the formation of organized micro®lament structures in transformed cells . Changes in the expression of some of the genes encoding components of the micro®laments have also been observed . It is not known whether p53-induced cell cycle arrest is also associated with characteristic changes in the organization of micro®lament structures and if p53 has any direct role in the synthesis and assembly of the components of the micro®lament structures.
Actin is a major component of the micro®laments and plays an important role in maintaining cell shape and movement (Small et al., 1993) . Actins are known to comprise six mammalian isoforms each encoded by separate genes (Vanderkerchove and Weber, 1978) . Smooth muscle a-actin isoform along with b and g non-muscle types constitute the three actin isoforms expressed in ®broblast cells. Sm a-actin expression is known to be transformation sensitive and also sensitive to growth signals in normal cells ). An inverse relationship between cellular proliferation and a-actin expression has been reported (Leavitt et al., 1985; . Actively proliferating smooth muscle cells and fibroblast cells are reported to contain low levels of the aactin isoform . Density arrest of growth or growth arrest following treatment with antimitotic agents is associated with increased expression of the a-actin isoform .
This study was undertaken to determine if p53-induced cell cycle arrest is associated with changes in the organization of the micro®lament structures and the transcription of sm a-actin gene and whether these changes are mediated directly or indirectly by p53. We demonstrate that p53-induced cell cycle arrest is associated with dramatic changes in the organization of the micro®laments and an increase in sm a-actin mRNA level. In addition, our studies show that wild type p53 can activate sm a-actin promoter activity in p53 null cell lines and that DNA damage can induce sm a-actin expression in a p53-dependent manner. We have mapped the p53 response element in the human sm a-actin promoter which can bind p53 in a gel shift assay and can confer stimulation by p53 when inserted into a heterologous promoter.
Results
Reorganization of micro®lament bundles and induction of a-actin mRNA following wild-type p53-mediated G1 arrest
The smooth muscle (sm) a-actin promoter is highly conserved between human, mouse and chicken genes (Reddy et al., 1990) . The a-actin promoter activity is repressed in transformed cell lines and derepressed in revertant cells (Kumar et al., 1992; Bushel et al., 1995) . Its activity is regulated by cell proliferation. Actively proliferating ®broblast cells and smooth muscle cells have low levels of a-actin; inhibition of cell proliferation, by density arrest or treatment with antimitotic agents, has been found to induce a-actin promoter activity Leavitt et al., 1985; . We have recently shown that antimitotic agents, such as Taxol, Vincristine, Vinblastine, Colchicine and Nocodazole can induce sm a-actin expression in ®broblast cells, concomitant with an increase in organized microfilaments . We were interested to see if p53-induced cell cycle arrest has any eect on the organization of the actin containing micro®laments and the transcription of the smooth muscle a-actin gene. For this purpose, we chose the transformed rat embryo 32°C 39°C a b Figure 1 Conditional increase in actin ®lament bundles in A1-5 cells expressing a temperature sensitive mutant p53. A1-5 transformed rat embryo ®broblast cells expressing a temperature-sensitive mutant p53 protein (alanine to valine substitution at amino acid 135), were grown on cover slips at 378C and shifted to either 328C or 398C and maintained for 24 h before ®xing in 3.7% formaldehyde. At 328C the p53 protein is predominantly in the wild-type conformation, whereas at 398C the protein is predominantly in the mutant conformation. Actin ®laments were visualized using rhodamine-conjugated phalloidin. Photographs shown are two examples of cells maintained at the two temperatures ®broblast cells (A1-5) that express a temperaturesensitive murine mutant p53 protein (Martinez et al., 1991) . The temperature sensitive p53 gene contains a point mutation that results in an alanine to valine substitution at amino acid residue 135 (Martinez et al., 1991) . At high temperature (398C), *80% of the protein is in the mutant conformation as determined by reactivity with conformation-dependent monoclonal antibodies and the cells grow exponentially (Martinez et al., 1991) . In contrast, at low temperature, (328C), *80% of the p53 is in the wild-type conformation and the cells are growth arrested in the G1 phase of the cell cycle (Martinez et al., 1991) . A1-5 cells grown at 378C were plated on cover slips and shifted to either 398C or 328C. The cells were incubated for 24 h at the respective temperature and the actin ®laments were examined, using rhodamine labeled phalloidin staining. As shown in Figure 1 , the A1-5 cells maintained at 328C showed a signi®cant increase in actin ®lament bundles, compared to the ones maintained at 398C. The actin ®laments in A1-5 cells grown at 398C were more diused in the cytoplasm which is a characteristic feature of the transformed phenotype (Pollack et al., 1975) . Following incubation of the A1-5 cells at the respective temperatures for 24 h, total Poly(A) + containing RNA was isolated and the smooth muscle a-actin mRNA was quantitated using RT ± PCR method as described under Materials and methods.
As an internal control, a 983 bp fragment corresponding to Glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA was ampli®ed. The three actin isoforms expressed in ®broblast cells (a, b and g) show extensive homology at the nucleotide level which makes the detection of the a-actin speci®c message, by Northern blot analysis, very dicult. Hence, the RT ± PCR method was employed to quantitate the a-actin message. As shown in Figure 2 , the 302 bp fragment corresponding to the rat smooth muscle a-actin mRNA was present at a very low level in A1-5 cells grown at 398C, and was elevated more than 20-fold in cells shifted to 328C. These results show a distinct correlation between wild ± type p53 function and aactin mRNA level and the organization actin ®lament bundles. These results support our previous observations regarding the correlation between a-actin expression and the presence of organized actin ®lament bundles .
Wild-type p53 transactivates human smooth muscle a-actin promoter
The increase in a-actin mRNA level seen under these conditions may be a direct eect of p53 protein binding to a regulatory element within the promoter and stimulating its activity. Alternatively, wild-type p53 may in¯uence the physiology of the cell in such a way that the a-actin promoter may become transcriptionally active. In order to see if changes in a-actin mRNA level seen under these conditions are due to a direct eect of p53, we used Saos-2 human osteogenic sarcoma cell line (Masuda et al., 1987) and the (10)1 spontaneously arising, immortalized mouse ®broblast cell line (Harvey and , both of which have no endogenous p53 protein expressed. These two cell lines are devoid of p53 protein because of major deletions in the 5' region of the p53 gene. The cell lines were transfected with plasmid paACAT containing human a-actin promoter linked to CAT reporter gene along with expression plasmids carrying wild-type (pC53-SN3) or mutant p53 (pC53-SNX3) cDNAs under the control of CMV promoter (Kern et al., 1991) . As a control, pcDNA3 vector plasmid carrying CMV promoter sequences were used in cotransfection experiments. Forty eight hours after transfection, the cells were harvested and analysed for chloramphenicol acetyl transferase (CAT) activity. As shown in Figure 3 , paACAT is expressed poorly when transfected into either Saos-2 ( Figure 3a ) or (10)1 cells ( Figure 3b ). Cotransfection with wild-type p53 expression vector (50 ng), however, led to an eightfold induction of CAT activity, compared to cotransfection with either pCDNA3 vector control or mutant p53 expression vector. Higher concentration (100 ng) of wild ± type p53 seemed to transactivate less than 50 ng. Repression of transcription by higher doses of p53 has been observed with the Rb promoter that is transactivated by wild ± type p53 (Osifchen et al., 1994) . A slight activation of the paACAT was observed with the mutant p53 expression vector in Saos-2 cells, compared to control ( Figure 1a ). The mutant used in these experiments Ala 143, is known to exhibit a degree of wild ± type DNA binding and transcriptional function (Chen et al., 1993) . These results indicate that wild-type p53 can transactivate aactin promoter in p53 null cell lines. , were grown at 378C and shifted to either 328C or 398C and maintained for 24 h. Poly(A) + containing RNA was isolated from A1-5 cells maintained at the respective temperatures and the a-actin mRNA level was quantitated by RT ± PCR method using oligonucleotides speci®c for the rat a-actin mRNA. A 302 bp fragment of the rat a-actin cDNA was ampli®ed using oligonucleotides speci®c for the rat sm a-actin cDNA sequence. As an internal control, a 983 bp fragment corresponding to glyceraldehyde 3-phosphate dehydrogenase (G3PDH) cDNA was ampli®ed by RT ± PCR using primers supplied by Clontech Laboratories (San Diego, CA). First strand cDNA was synthesized using oligo (dT) primers and reactions without reverse transcriptase were included as controls. PCR reactions were performed in the presence of [a 32 P]d(CTP) and analysed electrophoretically on a 10% poly acrylamide gel. The gel was dried and exposed to Kodak-XAR ®lm with an intensifying screen at 7708C. The arrows indicate the presence of speci®c PCR products A p53 response element is located in the region 7670 to 7255 of the a-actin promoter In order to map the region of the a-actin promoter that mediates the wild ± type p53-dependent activation, deletion mutants of human a-actin promoter linked to the luciferase reporter-gene were cotransfected along with wild ± type p53 or mutant p53 expression vectors into Saos-2 cell lines. As shown in Figure 4 , deletion of sequences 7894 to 7670 (as in paAAccI Luc) had no eect on the activation of a-actin promoter driven luciferase activity by wild-type p53. However, deletion of sequences 7670 to 7255 (as in paAPstIluc) abolished p53 mediated activation of a-actin promoter activity, suggesting that p53 responsive sequences are located in this region. Previous studies have shown that deletion of sequences between 7670 to 7255 resulted in a threefold decrease in basal promoter activity in Rat-2 cells, indicating the presence of a positive regulatory element in this region .
Identi®cation of a p53 response element in the a-actin promoter
Further examination of this region revealed the presence of a putative binding site for the p53 tumor suppressor protein, between 7312 to 7291 from the transcription start site. The homology of the putative p53 response element sequences in the a-actin promoter, to the p53 consensus sequence is shown in Figure 5a . The putative p53 response element in the aactin promoter diers from the p53 consensus sequence at four positions. The changes at these positions seem to be well tolerated and have been found in a number Figure 3 Wild ± type p53 transactivates human smooth muscle a-actin promoter in Saos-2 and (10)1 cells. Cells were transfected with paACAT plasmid DNA (20 mg), along with indicated concentrations of pCDNA3 vector (control), or wild ± type p53 cDNA expression plasmid (WT), or mutant p53 expression plasmid (MT) for 18 h. Cells were washed twice with PBS and a fresh medium was added. Following 48 h of incubation, cell extracts were assayed for CAT activity after normalizing for equal amounts of protein.
The CAT assays were repeated a minimum of three times with independent DNA preparations. (a) Saos-2 human osteogenic sarcoma cell line; (b) (10)1 spontaneously arising immortalized murine ®broblast cell line Figure 4 Mapping the wild-type p53 response element to the region 7670 to 7255 in the human smooth muscle a-actin promoter. 5' deletion mutants of human smooth muscle a-actin promoter linked to luciferase reporter-gene were cotransfected along with pCDNA3 (C), or wild ± type p53 expression plasmid (Wt) or mutant p53 expression plasmid (Mt) into Saos-2 cells. Cells were harvested 48 h after transfection and analysed for Luciferase activity as described in Materials and methods of p53 binding sites (Baker et al., 1990; El-Deiry et al., 1992 , 1993 Wu et al., 1993; Barak et al., 1993; Kastan et al., 1992; Okamoto and Beach, 1994; Zambetti et al., 1992) . This sequence also showed very good homology to the p53 response element present in the mck promoter region . The p53 response element in the mck promoter is a 50 bp sequence that is believed to contain three p53 half consensus sites. As shown in Figure 5b , the homology between the two sequences extends to both the 5' end and 3' end of the major p53 consensus site. Next, we wanted to see if this segment of the a-actin promoter can confer p53-dependent activation to heterologous promoters. One or two copies of the oligonucleotides (20mer) corresponding to the minimal p53 response element were subcloned into the plasmid The p53 response element in the a-actin promoter can confer p53-dependent transactivation to a heterologous promoter in Saos-2 cells. Homology of the p53 response element in the human smooth muscle a-actin promoter to the p53 consensus sequence and the p53 binding sequence in the muscle creatine kinase promoter is shown. The numbers in parenthesis denote the speci®c nucleotide usage (%) within the two monomers of the consensus binding site. Oligonucleotides corresponding to region 7312 to 7291 of the human smooth muscle a-actin promoter, were subcloned into the plasmid containing AdMLP/TdT minimal promoter linked to the CAT reporter-gene. Plasmids carrying either one or two copies of the 20 bp sequence were transiently transfected into Saos-2 cells along with either wild ± type p53 (WT) or mutant p53 (MT) expression vectors or pCDNA3 (C) vector DNAs. As a control, the plasmid containing two copies of the GADD45 p53 response element linked to the TdT minimal promoter-CAT gene was cotransfected along with the wild ± type (p53) or mutant p53 (mt) expression vectors or pCDNA3 vector control (-). Cells were harvested 48 h after transfection and CAT activities were determined as described above. The plasmid carrying two copies of the minimal element linked to AdMLP/TdT-CAT gene was stimulated signi®cantly by wild ± type p53 and the plasmid carrying one copy of the element was not stimulated by wild ± type p53. In addition oligonucleotides (51mers) corresponding to the region 7334 to 7284 of the a-actin promoter, were subcloned into the Ad MLP/TdT-CAT reporter-gene vector and plasmids containing either one or two copies of the sequence were transiently transfected into Saos-2 cells along with wild ± type or mutant p53 expression vectors or pCDNA3 vector control. Cells were harvested and analysed for CAT activity as described above. The construct containing one copy of the 51mer sequence was stimulated about nine-fold by wild-type p53 and the construct carrying two copies of the 51mer sequence was stimulated 18-fold by wild-type p53 expression vector compared to either mutant p53 expression vector or pCDNA3 vector control vector pBlue 1634 which encodes the minimal hybrid promoter consisting of the adenovirus major late TATA sequences and the terminal deoxynucleotide transferase initiation site (Ad MLP/TdT) fused to the CAT reporter gene . In addition, oligonucleotides (51mer) corresponding to the sequence 7334 to 7284 were also subcloned into the Ad MLP/ TdT minimal promoter-CAT gene. The resulting plasmid constructs were transiently transfected into Saos-2 cells, along with either wild-type or mutant p53 expression vectors or pCDNA3 vector control. As a control, a construct containing one copy of the Gadd45 derived p53 response element linked to the TdT minimal promoter-CAT gene was transiently transfected along with wild-type or mutant p53 expression vector or pCDNA3 vector into Saos-2 cells. The cells were harvested 48 h after transfection and the relative CAT activities were determined as described in Materials and methods. As shown in Figure 5a , one copy of the minimal p53 response element was unable to confer p53 dependent transactivation to the Ad MLP/TdT minimal promoter. However, two copies of the minimal p53 response element were able to confer signi®cant p53-dependent transactivation to the Ad MLP/TdT minimal promoter-CAT reporter gene. The 51 bp region from the aactin promoter that showed homology to the p53 binding site present in the mck promoter was also able to activate the Ad MLP/TdT minimal promoter in a wild-type p53-dependent manner in Saos-2 cells ( Figure  5b ). The fold activation observed with one copy of the 51 bp segment was 8.5-fold, whereas the fold activation observed with two copies was 18-fold. The mutant p53 failed to stimulate the promoter activity in these experiments. These results suggest that the minimal p53 response element (20 bp) was weakly activated, if at all, by wild-type p53, and the 51 bp sequence seems to be necessary for the optimal activation of a-actin promoter by wild-type p53. Thus sequences present on the 5' and 3' end of the p53 consensus sequence seem to be important for the p53-dependent activation of the a-actin promoter in Saos-2 cells. A similar result was observed with the mck-derived p53 response element . The 25 bp element from the mck promoter containing the TGCCT motif was not sucient to confer p53-dependent positive regulation to the test gene, whereas the 50 bp sequence was able to do so. p53 protein binds to the p53 response element of the a-actin promoter To con®rm that p53 is capable of binding speci®cally to the p53 response element from the a-actin promoter, 32 P-labeled 51 bp oligonucleotide corresponding to the region 7334 to 7284 was used in a gel shift assay (Figure 6 ), using baculovirus-derived recombinant p53 protein. The protein-DNA complexes were resolved by native polyacrylamide gel electrophoresis and visualized by autoradiography. The retarded mobility of the oligonucleotide observed in the presence of puri®ed p53 protein was competed by dierent oligonucleotides. The speci®c protein:DNA complexes were completely inhibited by the addition of 100-fold molar excess of unlabeled oligonucleotides corresponding to the p53 consensus sequence (Con p53), or the 51 bp of the aactin promoter-derived p53 response element (Actin p53), but not by the same amount of mutant p53 oligonucleotides (Mut p53) or by the non-speci®c oligonucleotides (Nonspeci®c). The retarded mobility of the probe in the presence of p53 protein was supershifted if PAb421 antibody, that recognizes wildtype p53 protein, was added to the reaction mixture. These results show that p53 binds speci®cally to the 51 bp of the p53 response element from the a-actin promoter.
Speci®c induction of a-actin mRNA by DNA damaging agents in cells expressing wild-type p53
Next, we were interested to see if DNA damaging agents that are known to induce p53 protein, have any eect on a-actin mRNA level and whether this induction was p53 dependent. For this purpose, the human colorectal carcinoma lines, RKO, RKO-E6 and SW 480 were exposed to ionizing radiation (IR) and total RNA was isolated. The RKO cell line has a wild ± type p53 gene and the activation of the G1 check point by IR has been well characterized for these cells (Kuerbitz et al., 1992; Kastan et al., 1991) . In RKO-E6 cells, the wild ± type p53 is inactivated by the expression of HPV-derived E6 protein, whereas SW -No extract -No competitor -Con p53 -Mut p53 -Nonspecific DNA -Actin p53 -pAb421 + Con -pAb421 + Mut -pAb421 + Actin p53 1 1 2 2 3 3 4 5 6 Figure 6 Wild-type p53 protein binds to speci®c DNA sequences in the p53-responsive region of the human a-actin promoter. Oligonucleotides corresponding to the 7334 to 7284 region of the a-actin promoter were end labeled with DNA polymerase I and [a 32 P] dCTP and subjected to electrophoretic mobility shift assay using 100 ng of baculovirus produced recombinant human p53 protein. For competition experiments, a 100-fold molar excess of unlabeled oligonucleotides corresponding to either p53 consensus sequence (Con p53) or mutant p53 sequence (Mut p53) or actin p53 sequence (Actin p53) or nonspeci®c DNA sequences (Nonspeci®c DNA) were included in the binding reactions. To observe supershift with PAb421 antibody, puri®ed p53 protein was preincubated with antibody before the addition of labeled oligonucleotides. The DNA-protein complexes were resolved on a 4% non-denaturing polyacrylamide gel in 0.5xTBE at 48C. The gels were dried and exposed to X-ray ®lm overnight 480 cells express mutant p53 (Kessis et al., 1993; Slichenmeyer et al., 1993; Kuerbitz et al., 1992; Kastan et al., 1991) . These cells lack IR induction of p53 and the activation of the G1 check point. The human sm aactin and G3PDH mRNA levels were quantitated by RT ± PCR, as described above. As shown in Figure 7 , sm a-actin mRNA level was elevated signi®cantly in RKO cells following exposure to IR, but not in the RKO-E6 and SW 480 cells, which have defective p53 function. Densitometric tracing of the autoradiogram indicated that the fold induction of a-actin mRNA following g-irradiation in RKO cells was about 20. A threefold increase in the G3PDH mRNA level was also observed consistently in these cells following girradiation. It is not clear if the slight increase in G3PDH mRNA seen in these cells represents a true response or a variation in the experimental technique. These results indicate that IR-mediated activation of p53 is associated with an induction of a-actin expression.
Discussion
Smooth muscle a-actin is one of the three isoforms expressed in ®broblast cells. Its expression is regulated by hormones, cell proliferation, and altered by pathological conditions including oncogenic transformation Leavitt et al., 1985; Kumar et al., 1992; . The a-actin promoter contains two serum response elements (SREs) that show homology to c-fos SRE and a hitherto uncharacterized positive element upstream to the SREs . An inverse relationship between a-actin expression and cellular proliferation has been demonstrated . Density arrest of growth or growth arrest in serum-free medium or following treatment with antimitotic agents was associated with increased a-actin promoter activity. A correlation between a-actin expression and the presence of organized micro®lament bundles has also been observed .
In this study, we have shown human sm a-actin is a direct transcriptional target of the p53 tumor suppressor protein. First, the a-actin mRNA is induced under conditions which are known to induce p53 expression. In A1-5 cells expressing a temperature sensitive mutant p53 gene, a-actin mRNA level is induced under conditions of wild ± type p53 geneinduced G1 cell cycle arrest. In RKO cells expressing wild ± type p53, increase in p53 protein following girradiation is also associated with an increase in a-actin mRNA level. Second, a speci®c p53 binding site was identi®ed upstream of the a-actin gene. Finally, this p53 binding site functions as a p53-dependent cisacting element in a transient transfection assay and can bind puri®ed p53 protein in a gel mobility shift assay.
The p53 tumor suppressor protein has been proposed to mediate its diverse biological eects in response to various external stimuli, by activating or repressing the transcription of particular set of target genes. Many of the proteins encoded by these target genes participate in either cell cycle control or apoptotic pathway. The transcriptional stimulation of a-actin promoter by p53 represents the ®rst example of a cytoskeletal gene that contains a functionally de®ned p53-response element in its promoter. What is the functional signi®cance of the regulation of the a-actin gene by p53? Cell cycle progression and cell cycle arrest is associated with characteristic changes in the organization of micro®lament structures. The sm aactin isoform is found to associate predominantly with the stress ®ber structures or micro®lament bundles, whereas b-actin is restricted to the lamellipodia or membrane rues (DeNofrio et al., 1989; Herman, 1993) . Recently, it has been shown that expression of a-actin isoform correlates with retardation of motility +  ------+  +  +  +  +  SW 480  SW 480  RKO  RKO  RKO-E6  RKO-E6 IR IR a b Figure 7 Quantitation of a-actin mRNA level in g-irradiated human cell lines. Total RNA isolated from control of g-irradiated SW 480, RKO and RKO-E6 cells were subjected to RT ± PCR analysis, as described in the legend to Figure 1 , using oligonucleotides speci®c for human a-actin cDNA. (a) A 302 bp fragment of the human a-actin cDNA was ampli®ed. (b) As an internal control a 983 bp fragment corresponding to glyceraldehyde 3-phosphate dehydrogenase (G3PDH) cDNA was ampli®ed by RT ± PCR in ®broblast cells (Ronnov-Jessen and Peterson, 1996) . Sm a-actin negative cell lines migrate at a signi®cantly faster speed than the corresponding a-actin positive strains. Moreover, depletion of a-actin by either electroporation of speci®c monoclonal antibody or antisense oligonucleotides leads to a signi®cantly enhanced motility in ®broblast cells. Hence, it was proposed that an important function of a-actin is to immobilize cells (Ronnov-Jessen and Peterson, 1996) . Thus a-actin expression seems to correlate with the formation of well organized micro®laments and a reduction in motility. The p53-induced cell cycle arrest may be associated with cell spreading and development of well organized micro®lament structures. The ability of p53 to directly activate the transcription of the aactin gene may ensure that micro®lament bundles are organized in cells undergoing cell cycle arrest. It is currently not known if coordinate induction of other micro®lament associated proteins is required for the formation of well organized micro®lament structures.
Our results suggest that p53 mediates not only the induction of genes whose products participate directly in cell cycle check point, or in the apoptotic pathway, but also those that participate in the micro®lament organization. These studies suggest a novel role for p53 in the cytoskeletal organization.
Materials and methods

Cell culture and transfections
The human osteogenic sarcoma cell line Saos-2 was obtained from American Tissue Culture Collection (ATCC, HTB-85). The murine BALB/c embryo ®broblast cell line 10(1) and the A1-5 cells derived from rat embryo ®broblast cells transformed by a temperature sensitive mutant murine p53 gene and an activated ras gene, were a kind gift from Dr Arnold Levine (Princeton University, NJ). These cells were maintained as monolayer cultures in Dulbecco's minimal essential medium (DMEM) containing 10% fetal bovine serum, 2 mM glutamine, penicillin-G (100 m/ml), and streptomycin (100 mg/ml) at the appropriate temperature in a humidi®ed 5% CO 2 atmosphere. The human colorectal carcinoma lines RKO, RKO-E6 and SW 480, characterized previously (Kessis et al., 1993; Slichenmeyer et al., 1993; Kuerbitz et al., 1992) were grown in modi®ed Eagles minimal essential medium with 10% fetal calf serum. Cells were irradiated at 4 Gy with a 137 Cs source at a dose rate of approximately 100 cGy/min and cells were harvested for RNA isolation 3 h after irradiation.
Approximately, 1610 6 Saos-2 cells and 5610 5 10(1) cells were plated in a 10 cm 2 tissue culture dishes in 10 ml of DMEM and maintained at 378C for 24 h prior to transfecting with calcium phosphate:DNA precipitates for 18 h as described before (Kumar et al., 1992; Bushel et al., 1995) . After incubation of cells for an additional 48 h at 378C, the cell extracts were processed and CAT activities were determined as described before . The CAT assays were repeated at least three times with independent DNA preparations. Luciferase activitites in cell extracts were determined as described before (Kumar et al., 1992) .
Plasmids
The plasmid paACAT and deletion mutants of a-actin promoter have been described before (Kumar et al., 1992) . The deletion mutants were subcloned into a plasmid containing luciferase reporter gene (gift from Ron Prywes, Columbia University). Plasmids pC53-SN3 and pC53-SCX3 containing wild ± type and mutant cDNAs respectively, under the control of CMV promoter, were a kind gift from Dr Bert Vogelstein (The Johns Hopkins University School of Medicine). Plasmid pC53-SCX3 expresses a mutant protein with a substitution of Ala for Val-143 . Plasmid p50-2 containing two copies of the p53 response element from the muscle creatine kinase promoter linked to the Ad MLP/TdT gene initiator minimal promoter-CAT reporter gene, was a kind gift from Dr Arnold Levine .
A synthetic double stranded oligonucleotide corresponding to the region 7334 to 7284 of the sm a-actin promoter (5'-TGGCATCCTCTGTGG AATGTG CAAACCATGCCTGC-ATCTGCCCATTACCCT-3') was subcloned into the SmaI site of pBlue 1634 which is a pBluescript vector containing a chimeric Ad MLP/TdT gene initiator minimal promoter linked to the CAT reporter gene . The resulting transformants were sequenced to identify the plasmids containing one copy (pAct1xRE-CAT) and two copies (pAct2xRE-CAT) of the a-actin p53 response element oriented in the forward direction with respect to TATA box. A synthetic double stranded oligonucleotide consisting of the following sequence, corresponding to the region 7312 to 7291 of the aactin promoter, 5'-AACCATGCCTGCATCTGCCC-3' was subcloned into the SmaI site of the pBlue1634 to generate pAct1xMinRE CAT plasmid containing a single copy of the minimal p53 response element oriented in the forward direction. To generate the plasmid pAct2xMinRE CAT containing two copies of the minimal p53 response element in pBlue 1634 vector, a synthetic double stranded oligonucleotide of the following sequence 5'-AACCATGCCTGCATCTGCC-CAACCATGCCTGCATCTGCCC-3' was used. To derive the plasmid pGADD451xRE, a synthetic double-stranded oligonucleotide of the sequence 5'-CTTAATTCTCGAGCAGAAC-ATGTCTAAGCATGCTGGGCTCGAAGG-3' was subcloned into the same vector. All plasmids were sequenced to verify the orientation of the fragments.
Gel mobility shift assay
A synthetic oligonucleotide (52mer), referred to as Act p53, corresponding to the -region 7334 to 7284 of the smooth muscle a-actin promoter was used in the gel mobility shift experiments. The p53 consensus oligonucleotide sequence referred to as the Con p53 is 5'-GGACATGCCCGGG-CATGTCC-3'. It has a palindromic p53 binding site to which p53 binds with high anity (Kern et al., 1991) . The mutant p53 consensus sequence, referred to as mutant Con p53, is 5'GACATGGGGCCCCATGTC-3'. This sequence contains an inversion of the core nucleotides resulting in the failure of p53 to bind to the sequence. The non-speci®c sequence referred to as Mef-1 has the following sequence, 5'-CAGGCAGCAGGTGGGGG-3'. The oligonucleotides were purchased from Gibco-BRL (Gaithersburh, Md). Oligonucleotides were end-labeled with 32 P, gel puri®ed and used in gel shift-assays as described before . In brief, the DNA-binding reactions contained 100 ng of puri®ed recombinant p53 protein (gift from Dr Maureen Murphy, Princeton, NJ), in DNA binding buer (25 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM MgCl 2 , 1 mM DTT, 0.1% NP-40, 5% glycerol, 0.5 mg/ml of BSA, 500 ng of poly dI:dC. Labeled oligonucleotides (5610 4 c.p.m./ng) were added in the end. For the competition experiments, a 100-fold molar excess of either Con p53, Mut Con p53, Mef-1 or Act p53 oligos were included in the reaction mixture prior to the addition of labeled probe. For the supershift experiments, 100 ng of the antibody pAb421 (Oncogene Sciences) was added to the reaction mixture prior to the addition of labeled probe. The DNA-protein complexes were resolved on a 4% non-denaturing polyacrylamide gel in 0.56TBE buer at 48C. The gels were dried and exposed to X-ray ®lm overnight at 7708C.
Reverse transcriptase-polymerase chain reaction to quantitate a-actin mRNA level RT ± PCR method to quantitate mRNA levels in cells was carried out as described by Brenner et al., (1989) . A1-5 cells were plated at a density of 5610 5 cells per 10 cm dish and incubated at 378C for 1 day prior to shifting to either 328C or 398C. Forty-eight hours later, total cellular RNA was isolated by extracting cells with the guanidinium thiocyanate, phenol/chloroform mixture using the total RNA isolation kit from Clontech (San Diego, CA). First strand cDNA synthesis and PCR reactions were carried out using the Advantage RT ± PCR kit (Clontech), using equal amounts (100 ng) of total poly(A) + RNA. A 302 bp fragment of the rat a-actin cDNA sequence was ampli®ed using the following oligonucleotide primers corresponding to the rat a-actin cDNA (McHugh and Lessard, 1988) ; The sense primer is 5'-AAATATTCTGTCTGCATCGGCGG-3', and the antisense primer is 5'-AAGGGTAGCCA-CATGTCTGATTT-3'. To quantitate the a-actin mRNA level in human cell lines following g-irradiation, a separate set of primers were used to amplify the 320 bp segment of the human a-actin cDNA; sense primer 5'-AAATACTCT-GTCTGGATCGGTGGCTCC-3' and antisense primer is 5' -CACATAG GTA ACGAGTCAGAGCTTTGGCTA -3'. As an internal control in these experiments, a 983 bp fragment corresponding to the glyceraldehyde 3-phosphatedehydrogenase was ampli®ed using the set of primers supplied by Clontech (San Diego, CA). PCR reactions were performed in the presence of [a- 32 P]dCTP and analysed on a 10% poly acrylamide gel. The gel was dried and exposed to X-ray ®lm overnight at 7708C.
Indirect immuno¯uorescence microscopy
A1-5 cells were grown at 378C on coverslips in tissue culture dishes and maintained at either 328C or 398C for 48 h before ®xing with 3.7% formaldehyde in PBS for 10 min at room temperature. The actin ®laments were immunostained using rhodamine conjugated to phalloidin as described before .
